Last updated: April 12, 2023
Sponsor: UMC Utrecht
Overall Status: Active - Recruiting
Phase
N/A
Condition
Aneurysm
Treatment
N/AClinical Study ID
NCT05828576
22-781
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient older than 18 years registered in the CAR treated with conservative therapy
- Willingness and ability to participate in all scheduled procedures outlined in theprotocol
- Understanding of the Dutch language
- Patient is able and willing to give informed consent.
Exclusion
Exclusion Criteria:
- Inclusion criteria are not met
- Subjects registered in the CAR that have undergone surgical or endovascular treatmentof the ECAA
- Contradictions for MRI, such as 1) metallic objects in or around the body (e.g.cardiac implantable electronic device such as pacemakers and implantable cardioverterdefibrillators (ICD); 2) claustrophobia, 3) pregnancy.
- Other major neurological or psychiatric conditions affecting the brain and interferingwith the study design (e.g. multiple sclerosis, epilepsy, Parkinson's disease,vascular dementia)
- Unable to read or write the patient information letter and broad consent file
- Patients who have a life expectancy of less than two years due to a pre-existingcondition e.g. cancer
Study Design
Total Participants: 50
Study Start date:
March 30, 2023
Estimated Completion Date:
April 01, 2025
Study Description
Connect with a study center
UMCU
Utrecht, Zuid Holland
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.